分子モデリングの世界市場レポート 2024

分子モデリングの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には15.4%の年間複合成長率（CAGR）で146億5,000万米ドルに成長すると予想されます。予測期間で予想される成長は、AIと機械学習アルゴリズムの分子モデリングへの統合、創薬と開発の需要の増加、材料科学での応用の拡大、精密医療と個別化された治療アプローチの採用、および医療の成長に起因すると考えられます。バーチャル上映での分子モデリングの活用。予測期間に予想される主な動向には、計算能力の進歩、AIと機械学習の統合、創薬と開発の継続的な成長、材料科学における応用の拡大、予測医学への注目の高まりなどが含まれます。

分子モデリング市場は、医薬品開発の勢いの高まりによって成長する準備ができています。医薬品開発には、新しい医薬化合物の発見、設計、試験、市場投入という複雑なプロセスが含まれます。 分子モデリングはこの過程で極めて重要な役割を果たし、分子相互作用の理解、タンパク質-リガンド複合体の安定性の評価、機能の信頼性の確保、薬効の評価に役立ちます。医薬品開発の注目に値する急増は明らかであり、カナダのアクセシビリティ基準は、2022年に約9,000の新規医薬品が臨床試験中であると報告しており、これは前年の約8,500の医薬品数からの大幅な増加を反映しています。この医薬品開発活動の急増は、分子モデリング市場の成長にとって重要な触媒です。

分子モデリング市場の原動力は、個別化医療の台頭です。個別化医療は、個人固有の遺伝的、分子的、臨床的特徴に基づいてヘルスケアの決定と治療を調整します。 分子モデリングはこのアプローチに不可欠であり、治療に対する個々の患者の反応の予測、個別化された薬物療法の設計、分子プロファイルに基づく治療計画の最適化を容易にします。 2022年、食品医薬品局の医薬品評価研究センター（CDER）は37の新しい分子実体（NME）を承認し、そのうち12を占める治療用NMEの約34％が個別化医療連合によって個別化医療として分類されました。（PMC）。個別化医療の隆盛は、分子モデリング市場を前進させる重要な原動力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の分子モデリング市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ソフトウェア
• サービス
• 世界の分子モデリング市場、アプローチ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 分子力学法アプローチ
• 量子化学アプローチ
• 世界の分子モデリング市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 医薬品開発
• 創薬
• その他の用途
• 世界の分子モデリング市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 製薬会社およびバイオテクノロジー会社
• 研究センターおよび学術機関
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の分子モデリング市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の分子モデリング市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 分子モデリング市場の競合情勢
• 分子モデリング市場の企業プロファイル
  • Thermo Fisher Scientific Inc.
  • BioNTech SE
  • Dassault Systemes SE
  • Bruker Corporation
  • Qiagen NV

第31章 その他の大手および革新的な企業

• Physiomics plc
• SilcsBio LLC
• Compugen Ltd.
• Certara Inc.
• Schrodinger Inc.
• Jubilant Biosys Ltd.
• Simulations Plus Inc.
• Genedata AG
• Labvantage-Biomax GmbH
• Acellera Ltd.
• Advanced Chemistry Development Inc.
• Molsoft LLC
• Nimbus Therapeutics Inc.
• Crown Bioscience Inc.
• OTAVA Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Molecular modeling involves the generation, representation, and/or manipulation of three-dimensional structures of chemical and biological molecules, along with determining physicochemical attributes. This process aids in understanding the Structural Activity Relationship (SAR) of biological molecules. Molecular modeling relies on computer programs and mathematical algorithms to predict and visualize the three-dimensional structure and properties of molecules.

The primary products of molecular modeling include software and services. Software encompasses a set of instructions, data, and programs that enable a computer or computing device to perform specific tasks, solve problems, or carry out operations. Molecular modeling employs approaches such as the molecular mechanics approach and quantum chemistry approach, particularly in applications such as drug development and drug discovery. End users of molecular modeling include pharmaceutical and biotechnology companies, research centers, academic institutions, and others.

The molecular modeling market research report is one of a series of new reports from The Business Research Company that provides molecular modeling market statistics, including molecular modeling industry global market size, regional shares, competitors with a molecular modeling market share, detailed molecular modeling market segments, market trends and opportunities, and any further data you may need to thrive in the molecular modeling industry. This molecular modeling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The molecular modeling market size has grown rapidly in recent years. It will grow from $7.15 billion in 2023 to $8.25 billion in 2024 at a compound annual growth rate (CAGR) of 15.3%. The growth observed in the historical period can be attributed to advancements in computational chemistry and molecular dynamics, the early application of molecular modeling in environmental and sustainability contexts, the improvement of visualization tools, the increased utilization of molecular modeling in enzyme and protein engineering, and the development of biomolecular modeling techniques.

The molecular modeling market size is expected to see rapid growth in the next few years. It will grow to $14.65 billion in 2028 at a compound annual growth rate (CAGR) of 15.4%. The anticipated growth in the forecast period can be attributed to the integration of AI and machine learning algorithms into molecular modeling, an increased demand for drug discovery and development, expanding applications in material science, the adoption of precision medicine and personalized treatment approaches, and the growing utilization of molecular modeling in virtual screening. Major trends expected in the forecast period include advancements in computational power, the integration of AI and machine learning, continued growth in drug discovery and development, an expansion of applications in material science, and a heightened focus on predictive medicine.

The molecular modeling market is poised for growth, driven by the increasing momentum in drug development. Drug development encompasses the intricate process of discovering, designing, testing, and bringing new pharmaceutical compounds to market. Molecular modeling plays a pivotal role in this journey, aiding in understanding molecular interactions, assessing protein-ligand complex stability, ensuring functional reliability, and evaluating drug efficacy. A noteworthy surge in drug development is evident, with Accessibility Standards Canada reporting around 9,000 novel medications undergoing clinical trials in 2022, reflecting a substantial increase from the previous year's approximate count of 8,500 drugs. This surge in drug development activities is a key catalyst for the growth of the molecular modeling market.

The driving force for the molecular modeling market is the rise of personalized medicine. Personalized medicine tailors healthcare decisions and treatments based on an individual's unique genetic, molecular, and clinical characteristics. Molecular modeling is integral to this approach, facilitating the prediction of individual patient responses to treatments, the design of personalized drug therapies, and the optimization of treatment regimens based on molecular profiles. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), and approximately 34% of therapeutic NMEs, accounting for 12 of them, were classified as personalized medicines by the Personalized Medicine Coalition (PMC). The ascendancy of personalized medicine is a significant driver propelling the molecular modeling market forward.

The molecular modeling market faces a constraint due to the scarcity of experienced healthcare personnel. Adequate knowledge and expertise among healthcare professionals are essential for the effective interpretation and application of molecular modeling data in medical research and drug development. A significant shortage of essential healthcare workers has been reported, with projections indicating a worsening deficit of over 3.2 million workers within the next five years, as per a report by Mercer in September 2021. This shortage of experienced healthcare personnel poses a hindrance to the widespread adoption and utilization of molecular modeling techniques in the healthcare and pharmaceutical industries, thereby limiting the growth of the molecular modeling market.

Major companies in the molecular modeling market are at the forefront of innovation, introducing new technologies such as molecular modeling platforms. These platforms are comprehensive software suites offering tools for visualizing, simulating, and analyzing molecules. For instance, Cresset Group unveiled Flare V7 in August 2023, representing a cutting-edge drug design platform that seamlessly integrates ligand and structure-based approaches to enhance small-molecule discovery. It incorporates ensemble docking, Quantum Mechanics (QM) and Quantitative Structure-Activity Relationship (QSAR) methodologies, and various tools, marking a significant advancement in molecular modeling.

In September 2022, Cadence Design Systems Inc. acquired OpenEye Scientific Software Inc. for $500 million. This acquisition positions Cadence Inc. to bolster its intelligent system design capabilities by integrating scientifically validated expertise and making strides into molecular modeling and simulation. OpenEye Scientific Software Inc. is renowned for its computational molecular simulation and modeling software, contributing to Cadence's foray into this dynamic domain.

Major companies operating in the molecular modeling market report are Thermo Fisher Scientific Inc., BioNTech SE, Dassault Systemes SE, Bruker Corporation, Qiagen N.V., Physiomics plc, SilcsBio LLC, Compugen Ltd., Certara Inc., Schrodinger Inc., Jubilant Biosys Ltd., Simulations Plus Inc. , Genedata AG , Labvantage-Biomax GmbH, Acellera Ltd., Advanced Chemistry Development Inc., Molsoft L.L.C., Nimbus Therapeutics Inc., Crown Bioscience Inc., OTAVA Ltd., Chemical Computing Group, Molport SIA, Optibrium Ltd., BioSolveIT GmbH, Cyclica Inc., Cresset Group, Cyrus Biotechnology Inc., 3D Molecular Designs LLC, Inhibrx Inc., Leadscope Inc.

North America was the largest region in the molecular modeling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular modeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the molecular modeling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The molecular modeling market consists of revenues earned by entities by providing services such as molecular modeling consultancy services, computational chemistry services, receptor-based and ligand-based virtual screening, and in silico screening and molecular modeling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular modeling market also includes sales of protein modeling and drug discovery tools, cheminformatics and computational chemistry databases, and visualization and molecular graphics tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Molecular Modeling Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on molecular modeling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for molecular modeling? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The molecular modeling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Software; Services
• 2) By Approach: Molecular Mechanics Approach; Quantum Chemistry Approach
• 3) By Application: Drug Development; Drug Discovery; Other Applications
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Research Centers And Academic Institutions; Other End Users
• Companies Mentioned: Thermo Fisher Scientific Inc.; BioNTech SE; Dassault Systemes SE; Bruker Corporation; Qiagen N.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Molecular Modeling Market Characteristics

3. Molecular Modeling Market Trends And Strategies

4. Molecular Modeling Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Molecular Modeling Market Size and Growth

• 5.1. Global Molecular Modeling Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Molecular Modeling Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Molecular Modeling Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Molecular Modeling Market Segmentation

• 6.1. Global Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Software
• Services
• 6.2. Global Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Molecular Mechanics Approach
• Quantum Chemistry Approach
• 6.3. Global Molecular Modeling Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Drug Development
• Drug Discovery
• Other Applications
• 6.4. Global Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Research Centers And Academic Institutions
• Other End Users

7. Molecular Modeling Market Regional And Country Analysis

• 7.1. Global Molecular Modeling Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Molecular Modeling Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Molecular Modeling Market

• 8.1. Asia-Pacific Molecular Modeling Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Molecular Modeling Market

• 9.1. China Molecular Modeling Market Overview
• 9.2. China Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Molecular Modeling Market

• 10.1. India Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Molecular Modeling Market

• 11.1. Japan Molecular Modeling Market Overview
• 11.2. Japan Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Molecular Modeling Market

• 12.1. Australia Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Molecular Modeling Market

• 13.1. Indonesia Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Molecular Modeling Market

• 14.1. South Korea Molecular Modeling Market Overview
• 14.2. South Korea Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Molecular Modeling Market

• 15.1. Western Europe Molecular Modeling Market Overview
• 15.2. Western Europe Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Molecular Modeling Market

• 16.1. UK Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Molecular Modeling Market

• 17.1. Germany Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Molecular Modeling Market

• 18.5. France Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Molecular Modeling Market

• 19.9. Italy Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Molecular Modeling Market

• 20.13. Spain Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Molecular Modeling Market

• 21.1. Eastern Europe Molecular Modeling Market Overview
• 21.2. Eastern Europe Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Molecular Modeling Market

• 22.1. Russia Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Molecular Modeling Market

• 23.1. North America Molecular Modeling Market Overview
• 23.2. North America Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Molecular Modeling Market

• 24.1. USA Molecular Modeling Market Overview
• 24.2. USA Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Molecular Modeling Market

• 25.1. Canada Molecular Modeling Market Overview
• 25.2. Canada Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Molecular Modeling Market

• 26.1. South America Molecular Modeling Market Overview
• 26.2. South America Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Molecular Modeling Market

• 27.1. Brazil Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Molecular Modeling Market

• 28.1. Middle East Molecular Modeling Market Overview
• 28.2. Middle East Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Molecular Modeling Market

• 29.1. Africa Molecular Modeling Market Overview
• 29.2. Africa Molecular Modeling Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Molecular Modeling Market, Segmentation By Approach, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Molecular Modeling Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Molecular Modeling Market Competitive Landscape And Company Profiles

• 30.1. Molecular Modeling Market Competitive Landscape
• 30.2. Molecular Modeling Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. BioNTech SE
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Dassault Systemes SE
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bruker Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Qiagen N.V.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Molecular Modeling Market Other Major And Innovative Companies

• 31.1. Physiomics plc
• 31.2. SilcsBio LLC
• 31.3. Compugen Ltd.
• 31.4. Certara Inc.
• 31.5. Schrodinger Inc.
• 31.6. Jubilant Biosys Ltd.
• 31.7. Simulations Plus Inc.
• 31.8. Genedata AG
• 31.9. Labvantage-Biomax GmbH
• 31.10. Acellera Ltd.
• 31.11. Advanced Chemistry Development Inc.
• 31.12. Molsoft L.L.C.
• 31.13. Nimbus Therapeutics Inc.
• 31.14. Crown Bioscience Inc.
• 31.15. OTAVA Ltd.

32. Global Molecular Modeling Market Competitive Benchmarking

33. Global Molecular Modeling Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Molecular Modeling Market

35. Molecular Modeling Market Future Outlook and Potential Analysis

• 35.1 Molecular Modeling Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Molecular Modeling Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Molecular Modeling Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer